Literature DB >> 23066463

Coexistent malignant peripheral nerve sheath tumor and lateral spinal meningoceles.

Lata Bhoir1, Pramod Nichat, Ashish Chug, Harish Verma.   

Abstract

Malignant peripheral nerve sheath tumor (MPNST) is a malignant spindle cell tumor of the soft tissue thought to be derived from the components of nerve sheath. MPNSTs are mainly located in the buttocks, thighs, brachial plexus, and paraspinal region. The objective of this article is to describe a case of neurofibromatosis type 1 who developed neurofibrosarcoma of the right lateral thoracic nerve with thoracic meningoceles, a rare coincidental finding which has not yet been reported in the English medical literature, and how both the conditions were managed in the same sitting.

Entities:  

Keywords:  Lateral thoracic meningocele; Neurofibromatosis type 1; malignant peripheral nerve sheath tumor; soft tissue sarcoma; thoracotomy

Year:  2012        PMID: 23066463      PMCID: PMC3461777          DOI: 10.4103/2006-8808.100353

Source DB:  PubMed          Journal:  J Surg Tech Case Rep        ISSN: 2006-8808


INTRODUCTION

Malignant peripheral nerve sheath tumor (MPNST) is a malignant spindle cell tumor of the soft tissue thought to be derived from the components of nerve sheath such as perineural fibroblasts or Schwann cells.[1] These tumors are treated as a subcategory of soft tissue sarcoma, in which they comprise 3–10% of all such tumors.[1] MPNSTs are rare tumors with an incidence of 0.001% in the general population.[2] Till date,very few cases of MPNSTs of the lateral thoracic nerve have been reported in the medical literature.[3] Coincidental meningoceles are further rare.

CASE REPORT

A 60-year-old male, a case of neurofibromatosis type 1, presented with swelling in the right axilla, with a rapid growth over 5–6 months. The patient had difficulty in raising the right upper limb above shoulders. He also had breathlessness on exertion. There was no history of trauma or tingling or numbness. On examination, there was 14×11 cm size swelling over the right lateral aspect of the thorax extending into the axilla, with the presence of dilated veins over it. The local temperature was normal. It was freely mobile over underlying structures. The overlying skin was nonadherent. There was winging of the scapula indicating the involvement of the lateral thoracic nerve [Figure 1a].
Figure 1

(a) Preoperative photo of the patient. (b) Photo showing tumor arising from the lateral thoracic nerve. (c) Photo showing lateral thoracic meningoceles. (d) Postoperative photo of the patient

(a) Preoperative photo of the patient. (b) Photo showing tumor arising from the lateral thoracic nerve. (c) Photo showing lateral thoracic meningoceles. (d) Postoperative photo of the patient The PA view of the chest X-ray showed a space-occupying lesion on the right side paraspinally extending from D2 to D7 [Figure 2].
Figure 2

X-Ray of the chest showing meningoceles as a mass lesion

X-Ray of the chest showing meningoceles as a mass lesion A CT scan of the thorax showed a mixed density mass of 14×11 cm arising from the neurovascular bundle with a heterogeneous enhancement on the postcontrast study. There was no evidence of calcification. A cystic lesion of about 8×5 cm size was also seen in the right intrathoracic paraspinal region [Figure 3a and c].
Figure 3

(a) CT scan of the tumor. (b) MRI showing both the tumor and the meningoceles. (c) CT scan showing lateral meningocele with a spinal defect and the tumor. (d) MRI lateral view showing the meningoceles

(a) CT scan of the tumor. (b) MRI showing both the tumor and the meningoceles. (c) CT scan showing lateral meningocele with a spinal defect and the tumor. (d) MRI lateral view showing the meningoceles As the nature of the intrathoracic paraspinal swelling was doubtful, magnetic resonance imaging (MRI) was done. MRI revealed widened D1–8 neural foramina on the right side with widened subarachnoid spaces. There was evidence of T2 hyperintense space-occupying lesions in the right paravertebral region from D1-2 to D7-8 levels which appeared lobulated and septated with well-defined walls, contiguous with each other, and extending into the spinal canal via large neural foramina. There was no internal enhancement on the postcontrast study suggestive of thoracic meningoceles/duralectasia [Figure 3b and d]. Tru-cut biopsy of the swelling indicated malignancy.

Surgical technique

In view of the presence of the lesions on the right side and history of breathlessness, a decision was taken to operate both the pathologies in the same sitting. Under general anesthesia,the patient was given a left lateral position with hyperabducted right arm. An elliptical incision was taken on the posterior axillary fold so as to remove the redundant skin along with the mass.

Procedure

Subcutaneous flaps were raised and a wide (5 cm from all sides) local excision was done. During dissection, it was found that the tumor was arising from the right lateral thoracic nerve. The nerve along with the mass was excised [Figures 1b and 4a & b].
Figure 4

(a) Intraoperative photo while raising skin flaps. (b) Tumor with the lateral thoracic nerve excised in TOTO. (c) Repair of meningocele defects being done with a G-patch (artificial dural patch)

(a) Intraoperative photo while raising skin flaps. (b) Tumor with the lateral thoracic nerve excised in TOTO. (c) Repair of meningocele defects being done with a G-patch (artificial dural patch) After the complete removal of the tumor, a right lateral thoracotomy was done to repair the meningoceles in the same position. The meningoceles were dissected till their openings into the defects and then the defects were repaired with a G-patch (artificial dural graft; Figures 1c and 4c). Intercostal and subcutaneous suction drains were kept before closure. The patient recovered uneventfully. The histopathology of the tumor suggested malignant spindle cell neoplasm, with areas of necrosis, hyalinization, and myxoid change with giant cell reaction to the tumor [Figure 5a and b].
Figure 5

(a) Histopathology scanner view (×4) showing tumor with areas of necrosis. (b) Histopathology photographic view (×10) showing tumor cells arranged in fascicles with nuclear pleomorphism

(a) Histopathology scanner view (×4) showing tumor with areas of necrosis. (b) Histopathology photographic view (×10) showing tumor cells arranged in fascicles with nuclear pleomorphism Immunohistochemistry (IHC) suggested malignant spindle cell neoplasm positive for vimentin with negativity for S100 indicating decreasing differentiation. Diagnosis of the MPNST was confirmed [Figure 6].
Figure 6

IHC positive for vimentin

IHC positive for vimentin In view of the likely residual microscopic disease, the patient was given adjuvant radiotherapy (RT). On follow-up at 6 months, the patient did not have local recurrence [Figure 1d].

DISCUSSION

The incidence of neurofibromatosis is about 1/3000 of the population.[45] The disease is characterized by a classical triad of skin lesions, mental deficiency, and skeletal deformities. It was described for the first time by Friedrieh Daniel von Recklinghausen in 1882.[6] Now we distinguish neurofibromatosis as types 1 and 2 (NF 1 and NF 2), which are the peripheral and the central forms of the disease, respectively.[57] As defined by the WHO, MPNSTs are malignant tumors arising from a peripheral nerve or showing a nerve sheath differentiation with the exception of tumors originating from the epineurium or the peripheral nerve vasculature.[8] Approximately, one-third of MPNSTs arise de novo, whereas the remainder represent the sarcomatous degeneration of a preexisting plexiform neurofibroma. MPNSTs are associated with genetic aberrations such as loss of the neurofibromatosis 1 gene protein product. MPNSTs occur in the third to sixth decade of life usually arising from medium and larger nerves. Tumor location has been found to be a strong prognostic factor, with those in the thoracic and retroperitoneum having worse outcomes.[2] In our patient, the MPNST was found to be arising from the right lateral thoracic nerve, suggesting a better prognosis with good surgical resection. The International Consensus Group has recommended that the current management of MPNSTs should be identical to that of any other soft tissue sarcomas (STSs),. Adjuvant RT should be considered for all intermediate- and high-grade lesions as well as low-grade tumors with positive margins.[9] Our patient also received RT as the tumor was negative for S100 which indicates decreasing differentiation. MPNSTs are more aggressive tumors compared with other STSs; hence, an attempt should be made for near total surgical debulking of the tumor. The supportive literature is generally in the context of sarcomas and is not specific to MPNSTs. The role of chemotherapy is limited to the treatment of metastatic disease. Local recurrences have been reported to vary from 52 to 88.9% for different sites. Metastasis, in the lungs and liver, ranged from 11.1 to 18%.[10] Disease-free survival and overall survival were reported to be approximately 64% and 30% at 5 years, respectively. The etiology of meningoceles in NF 1 remains controversial. The changes in neurofibromatosis can be classified as primary, which are related to mesodermal dysplasia; secondary, which result from the compressive effects of nerve sheath tumors; and mixed that combine the two previous. Ventrolateral meningoceles of the thoracic spine are secondary to congenital mesodermal dysplasia and hypoplastic bone changes.[11] Our patient had the meningoceles since a long time, but presented with symptoms like breathlessness along with the MPNST. We postulate that the MPNST arose in a preexisting neurofibroma in this patient of NF 1 who already was harboring lateral thoracic meningoceles. Such a case of co-existent meningoceles and MPNST has not been reported yet in any English medical literature.

CONCLUSION

Rarity of this tumor along with lateral spinal meningoceles made us to present this case with a multidisciplinary approach to tumor still undefined.
  9 in total

1.  Intrathoracic meningoceles and neurofibromatosis.

Authors:  S Erkulvrawatr; T El Gammal; J Hawkins; J B Green; G Srinivasan
Journal:  Arch Neurol       Date:  1979-09

2.  Intrathoracic meningocele associated with neurofibromatosis: case report.

Authors:  K N Dolynchuk; J Teskey; M West
Journal:  Neurosurgery       Date:  1990-09       Impact factor: 4.654

3.  Cervical meningocoele presenting as a neck mass in a patient with neurofibromatosis 1.

Authors:  B Freund; C Timon
Journal:  J Laryngol Otol       Date:  1992-05       Impact factor: 1.469

Review 4.  Thoracic and lumbar meningocele in neurofibromatosis type 1. Report of two cases and review of the literature.

Authors:  N G Rainov; V Heidecke; W Burkert
Journal:  Neurosurg Rev       Date:  1995       Impact factor: 3.042

5.  Spinal meningoceles in association with neurofibromatosis.

Authors:  P O'Neill; W J Whatmore; A E Booth
Journal:  Neurosurgery       Date:  1983-07       Impact factor: 4.654

6.  International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis.

Authors:  Rosalie E Ferner; David H Gutmann
Journal:  Cancer Res       Date:  2002-03-01       Impact factor: 12.701

7.  Malignant peripheral nerve sheath tumors of the skin.

Authors:  E George; P E Swanson; M R Wick
Journal:  Am J Dermatopathol       Date:  1989-06       Impact factor: 1.533

8.  Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases.

Authors:  J E Wanebo; J M Malik; S R VandenBerg; H J Wanebo; N Driesen; J A Persing
Journal:  Cancer       Date:  1993-02-15       Impact factor: 6.860

9.  Malignant peripheral nerve sheath tumors of the head and neck: a clinicopathological study.

Authors:  D S Vege; R F Chinoy; B Ganesh; D M Parikh
Journal:  J Surg Oncol       Date:  1994-02       Impact factor: 3.454

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.